Last reviewed · How we verify

NCT01195233: BioXtra

Comparison Study of BioXtra Spray and Mouth Rinse in Patient With Radiation-induced Xerostomia

Completed Phase 2 Last updated 18 April 2011
What this trial tests

Phase 2 trial testing bioxtra in Radiation-Induced Xerostomia in 20 participants. Completed in 1 September 2010.

Timeline
1 July 2010
Primary endpoint
1 August 2010
1 September 2010

Quick facts

Lead sponsorQazvin University Of Medical Sciences
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposesupportive care
Enrollment20
Start date1 July 2010
Primary completion1 August 2010
Estimated completion1 September 2010
Sites1 location across Iran

Drugs / interventions tested

Conditions studied

Sponsor

Qazvin University Of Medical Sciences

Who can join

18 and older, any sex, with Radiation-Induced Xerostomia. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The present study compared the efficacy of BioXtra spray and mouth rinse in the relief of radiotherapy-induced xerostomia in patients referred to Cancer Institute, Tehran Imam Khomeini Hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Qazvin University Of Medical Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01195233.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing